🇺🇸 Belimumab plus Late Vaccination in United States

Belimumab plus Late Vaccination (Belimumab plus Late Vaccination) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Belimumab plus Late Vaccination in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Belimumab plus Late Vaccination approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Belimumab plus Late Vaccination in United States?

Human Genome Sciences Inc., a GSK Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.